<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chinese <z:chebi fb="107" ids="27563">arsenic</z:chebi> drugs have been applied in Chinese medicine for several centuries </plain></SENT>
<SENT sid="1" pm="."><plain>Beginning from 1970s, <z:chebi fb="107" ids="27563">arsenic</z:chebi> containing drugs have been generally used for the treatment of malignant <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> including <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>No matter what ingredients of <z:chebi fb="107" ids="27563">arsenic</z:chebi> drugs were applied, either <z:chebi fb="0" ids="30621">arsenic trioxide</z:chebi>, <z:chebi fb="107" ids="27563">arsenic</z:chebi> <z:chebi fb="0" ids="48343">disulfide</z:chebi>, or <z:chebi fb="107" ids="27563">arsenic</z:chebi> containing Chinese herbal compositions including Qinghuang Powder and Realgar-Indigo naturalis formula, they <z:hpo ids='HP_0000001'>all</z:hpo> provided the distinct approaches for the management of malignant <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e>, and good clinical efficacy was obtained with mild adverse reactions </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, the mechanisms of action have been continually elucidated </plain></SENT>
</text></document>